These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28256019)

  • 1. Ipilimumab has efficacy in metastatic Merkel cell carcinoma: a case series of five patients.
    Winkler JK; Dimitrakopoulou-Strauss A; Sachpekidis C; Enk A; Hassel JC
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e389-e391. PubMed ID: 28256019
    [No Abstract]   [Full Text] [Related]  

  • 2. In brief: Avelumab (Bavencio) for metastatic merkel cell carcinoma.
    Med Lett Drugs Ther; 2017 Jul; 59(1521):e120. PubMed ID: 28699934
    [No Abstract]   [Full Text] [Related]  

  • 3. Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab.
    Thiem A; Kneitz H; Schummer P; Herz S; Schrama D; Houben R; Goebeler M; Schilling B; Gesierich A
    Acta Derm Venereol; 2017 Nov; 97(10):1252-1254. PubMed ID: 28761962
    [No Abstract]   [Full Text] [Related]  

  • 4. Real-world clinical outcomes with first-line avelumab in locally advanced/metastatic Merkel cell carcinoma in the USA: SPEAR-Merkel.
    Cowey CL; Liu FX; Kim R; Boyd M; Fulcher N; Krulewicz S; Kasturi V; Bhanegaonkar A
    Future Oncol; 2021 Jun; 17(18):2339-2350. PubMed ID: 33709776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined nivolumab and ipilimumab in non-resectable Merkel cell carcinoma.
    Saiag P; Blom A
    Lancet; 2022 Sep; 400(10357):976-977. PubMed ID: 36108656
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of a patient with HIV and metastatic melanoma with consequitive ipilimumab and nivolumab.
    Tomsitz D; Hein R; Biedermann T; Kohlmeyer J
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e26-e28. PubMed ID: 28662283
    [No Abstract]   [Full Text] [Related]  

  • 7. Pembrolizumab as first line treatment of Merkel cell carcinoma patients - a case series of patients with various co-morbidities.
    Bystrup Boyles T; Schødt M; Hendel HW; Krarup-Hansen A; Junker N
    Acta Oncol; 2020 Jul; 59(7):793-796. PubMed ID: 32285728
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-PD1 in Merkel cell carcinoma and cutaneous squamous cell carcinoma, description of five cases and recent data from the literature.
    Sellah D; Saint-Jean M; Peuvrel L; Khammari A; Quéreux G; Dréno B
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):e159-e161. PubMed ID: 30451326
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma.
    Lee B; Wong A; Kee D; Neeson P; Shackleton M; McArthur G; Sandhu S
    Ann Oncol; 2016 Jun; 27(6):1174-1177. PubMed ID: 26861600
    [No Abstract]   [Full Text] [Related]  

  • 10. Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients.
    Heppt MV; Schlaak M; Eigentler TK; Kähler KC; Kiecker F; Loquai C; Meier F; Tomsitz D; Brenner N; Niesert AC; Thonke R; Hauschild A; Berking C
    Ann Oncol; 2017 Dec; 28(12):3104-3106. PubMed ID: 28950303
    [No Abstract]   [Full Text] [Related]  

  • 11. Ipilimumab prolongs survival in advanced melanoma.
    Burki TK
    Lancet Oncol; 2016 Nov; 17(11):e481. PubMed ID: 27746107
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinical Trial.
    Lambert J; Marrel A; D'Angelo SP; Burgess MA; Chmielowski B; Fazio N; Gambichler T; Grob JJ; Lebbé C; Robert C; Russell J; Güzel G; Bharmal M
    Patient; 2020 Aug; 13(4):457-467. PubMed ID: 32472503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No recurrence of nivolumab-induced idiopathic thrombocytopenic purpura in a metastatic melanoma patient switched to ipilimumab.
    Takimoto R; Otsuka A; Kaku Y; Honda T; Kabashima K
    Eur J Dermatol; 2018 Feb; 28(1):84-85. PubMed ID: 29400292
    [No Abstract]   [Full Text] [Related]  

  • 14. Are checkpoint inhibitors a valuable option for metastatic or unresectable vulvar and vaginal melanomas?
    Quéreux G; Wylomanski S; Bouquin R; Saint-Jean M; Peuvrel L; Knol AC; Hanf M; Dréno B
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e39-e40. PubMed ID: 28750150
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report.
    Appelbaum J; Wells D; Hiatt JB; Steinbach G; Stewart FM; Thomas H; Nghiem P; Kapur RP; Thompson JA; Bhatia S
    J Immunother Cancer; 2018 Aug; 6(1):82. PubMed ID: 30170630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes of Metastatic Melanoma Treated With Checkpoint Inhibitors and Multisite Radiotherapy.
    Doyen J; Picard A; Naghavi AO; Thyss A; Passeron T; Lacour JP; Montaudié H
    JAMA Dermatol; 2017 Oct; 153(10):1056-1059. PubMed ID: 28746710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma.
    Failing JJ; Finnes HD; Kottschade LA; Allred JB; Markovic SN
    Melanoma Res; 2016 Dec; 26(6):609-615. PubMed ID: 27603551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse recurrent cutaneous melanoma of the scalp and neck successfully treated with volumetric modulated arc therapy and concurrent ipilimumab.
    Schmid RK; Harker-Murray A; Niemczyk K; Robbins JR
    Pract Radiat Oncol; 2018; 8(3):174-178. PubMed ID: 29122555
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy for Merkel cell carcinoma: a turning point in patient care.
    Chan IS; Bhatia S; Kaufman HL; Lipson EJ
    J Immunother Cancer; 2018 Mar; 6(1):23. PubMed ID: 29566749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East.
    Ascierto PA; Orlova K; Grignani G; Dudzisz-Śledź M; Fenig E; Chiarion Sileni V; Fazio N; Samimi M; Mortier L; Gebhardt C; Kramkimel N; Steven N; Bechter O; Arance A; Benincasa E; Kostkova L; Costa N; Lorigan P
    Int J Cancer; 2021 Dec; 149(11):1926-1934. PubMed ID: 34310716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.